p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)Daniela Milani, Veronica Tisato, Enrico Zauli et al.|Frontiers in Pharmacology|2022Cited by 34
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17Giulio Kleiner, Annalisa Marcuzzi, Lorenzo Caruso et al.|Experimental and Therapeutic Medicine|2015Cited by 19